Khan Najat bought RXRX
February 3, 2025 · Form 4 insider transaction
Khan Najat bought 8,049 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,049
Price
$0.00
Total value
N/A
InsiderKhan Najat
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after715,134
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This RSU vested immediately upon the grant date.